{"id":3354,"date":"2022-06-16T18:57:09","date_gmt":"2022-06-16T16:57:09","guid":{"rendered":"https:\/\/www.cdlifepharma.com\/cdlife_products\/hyprojoint\/"},"modified":"2022-06-16T19:08:58","modified_gmt":"2022-06-16T17:08:58","slug":"hyprojoint","status":"publish","type":"cdlife_products","link":"https:\/\/www.cdlifepharma.com\/en\/cdlife_products\/hyprojoint\/","title":{"rendered":"Hyprojoint"},"content":{"rendered":"<p>Osteoarthritis is a CHRONIC PATHOLOGY that causes damage to the cartilage and surrounding tissues and is characterized by:<\/p>\n<ul>\n<li><strong>ache<\/strong><\/li>\n<li><strong>rigidity<\/strong><\/li>\n<li><strong>loss of functionality<\/strong><\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p>Since 2019, the OARSI and ESCEO guidelines include <strong>hyaluronic acid infiltrations as a therapeutic option<\/strong>.<\/p>\n<p>Infiltrative therapy with hyaluronic acid<\/p>\n<ul>\n<li><strong>REDUCES pain<\/strong><\/li>\n<li><strong>IMPROVES joint function<\/strong><\/li>\n<li><strong>RESTORES the joint to normal conditions<\/strong><\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p>Hyaluronic acid <strong>protects, lubricates <\/strong>and<strong> absorbs the shocks <\/strong>suffered by the joint during movements.<\/p>\n<p><strong>Hyprojoint<sup>TM<\/sup><\/strong> is a sterile, non-pyrogenic, transparent and viscous solution of highly purified sodium salt hyaluronic acid resulting from bio-fermentation.<\/p>\n<p><strong>Hyprojoint<sup>TM<\/sup><\/strong> consists of 10 \/ mg \/ mL of <strong>hyaluronic acid<\/strong> sodium salt dissolved in a physiological <strong>sodium chloride phosphat<\/strong>e buffer (pH6.8-7.5).<\/p>\n<p><strong>Hyprojoint<sup>TM<\/sup><\/strong> is indicated for the <strong>treatment of pain<\/strong> caused by <strong>osteoarthritis<\/strong> (OA) in patients who have not had adequate responses to non-drug conservative therapy and simple analgesics (e.g. acetaminophen).<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Osteoarthritis is a CHRONIC PATHOLOGY that causes damage to the cartilage and surrounding tissues and is characterized by: ache rigidity loss of functionality &nbsp; Since 2019, the OARSI and ESCEO guidelines include hyaluronic acid infiltrations as a therapeutic option. Infiltrative therapy with hyaluronic acid REDUCES pain IMPROVES joint function RESTORES the joint to normal conditions [&hellip;]<\/p>\n","protected":false},"featured_media":3343,"template":"","applicazione":[178,177,179],"brand":[170],"zona":[176],"class_list":["post-3354","cdlife_products","type-cdlife_products","status-publish","has-post-thumbnail","hentry","applicazione-improved-joint-function","applicazione-pain-reduction","applicazione-restoration-of-normal-joint-conditions","brand-hyprojoint","zona-joints"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.cdlifepharma.com\/en\/wp-json\/wp\/v2\/cdlife_products\/3354","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cdlifepharma.com\/en\/wp-json\/wp\/v2\/cdlife_products"}],"about":[{"href":"https:\/\/www.cdlifepharma.com\/en\/wp-json\/wp\/v2\/types\/cdlife_products"}],"version-history":[{"count":2,"href":"https:\/\/www.cdlifepharma.com\/en\/wp-json\/wp\/v2\/cdlife_products\/3354\/revisions"}],"predecessor-version":[{"id":3356,"href":"https:\/\/www.cdlifepharma.com\/en\/wp-json\/wp\/v2\/cdlife_products\/3354\/revisions\/3356"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cdlifepharma.com\/en\/wp-json\/wp\/v2\/media\/3343"}],"wp:attachment":[{"href":"https:\/\/www.cdlifepharma.com\/en\/wp-json\/wp\/v2\/media?parent=3354"}],"wp:term":[{"taxonomy":"applicazione","embeddable":true,"href":"https:\/\/www.cdlifepharma.com\/en\/wp-json\/wp\/v2\/applicazione?post=3354"},{"taxonomy":"brand","embeddable":true,"href":"https:\/\/www.cdlifepharma.com\/en\/wp-json\/wp\/v2\/brand?post=3354"},{"taxonomy":"zona","embeddable":true,"href":"https:\/\/www.cdlifepharma.com\/en\/wp-json\/wp\/v2\/zona?post=3354"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}